PolicyStreet Offers Uncapped 10% Car Insurance Savings with '10+10' Promo

The '10+10' Promo combines a 10% discount on car insurance and an additional RM10 at checkout, with FREE road tax available towards the end of each month.

KUALA LUMPUR, Malaysia, Dec. 30, 2025 /PRNewswire/ -- PolicyStreet is rolling out its largest car insurance promotion to date with the launch of its '10+10' Promo, offering an uncapped 10% discount on car insurance premiums alongside an additional RM10 discount. Complemented by their free road tax offering, the campaign is designed to help Malaysians compare insurers and choose coverage that delivers the greatest value, best suited for their lifestyle.

"Running from 2 January until the end of April, the '10+10' Promo is structured around how Malaysians spend at different points of the month, as financial priorities and cashflow needs are not the same for everyone. Our goal is to make car insurance more accessible by offering meaningful savings and flexible options that cater to Malaysians across different financial situations," said Yen Ming Lee, Co-founder and Group Chief Executive Officer of PolicyStreet.

From the 1st to the 24th of each month, Malaysians can enjoy a 10% discount on their car insurance base premium after Non-Claim Discount (NCD), along with an additional RM10 discount provided by PolicyStreet, which will be reflected at the checkout page. The promotion is available daily during two dedicated sale windows, from 10 am to 11 am and 10 pm to 11 pm. For Malaysian drivers with base premiums of RM1,000 and above after NCD, the uncapped 10% discount translates into at least RM100 in savings.

From the 25th until the last day of the month, the campaign shifts focus to affordability, offering free road tax capped at RM90. Malaysians can pair this promotion with Buy Now, Pay Later (BNPL) options such as Atome, SPay Later, or Grab PayLater, helping to manage upfront costs while maintaining essential coverage.

As with PolicyStreet's previous sales campaigns, customers can request a quotation via car.policystreet.com and complete payment during the designated sales windows to enjoy the promotion, no promo codes needed. Quotation links remain valid for up to two weeks, allowing customers sufficient time to review their options before proceeding with payment.

By running the campaign across the entire first quarter, PolicyStreet aims to give Malaysians the time and flexibility to plan, compare policies across insurers, and make informed decisions, rather than rushing into renewals out of necessity.

Beyond discounts, PolicyStreet continues to offer Malaysians a seamless digital experience, enabling them to compare car insurance policies across insurers, renew road tax, and explore flexible payment options, all in one place.

As Malaysians look to stay on track with their financial goals in 2026, PolicyStreet's '10+10' Promo reinforces a simple idea: meaningful savings should not come at the expense of choice. By combining smarter comparisons with meaningful discounts and flexible payment options, Malaysians can make more informed car insurance decisions as they start the year.

For more information on the '10+10' Promo, visit https://policystreet.com.my/tnc.

About PolicyStreet

PolicyStreet is a regional full-stack insurance technology (insurtech) group of companies providing cutting-edge digital insurance solutions to businesses and consumers in Southeast Asia and Australia.

PolicyStreet works directly with over 40 life, general insurers and Takaful providers globally to offer a comprehensive range of products and services, which includes but is not limited to embedded insurance, customised employee benefits, financial advisory and aggregation of insurance, as well as the development of digital solutions to make insurance purposeful and simple for businesses and consumers.

As a licensed Reinsurer, General Insurer and Takaful Operator by the Labuan Financial Services Authority (LFSA), an approved Financial Adviser and Islamic Financial Adviser by Bank Negara Malaysia (BNM), and a licensee of the Australian Financial Services License by the Australian Securities and Investments Commission (ASIC), PolicyStreet is able to underwrite, customise policies, and provide unbiased advice to its clients and partners worldwide.

PolicyStreet is backed by the Malaysian sovereign wealth fund, Khazanah Nasional Berhad, and serves over 10 million customers with over US$ 10 billion in sum insured. In 2024, PolicyStreet was recognised as "Fintech of the Year" at The Asset's Triple A Digital Awards and was the winner of the Fintech Excellence Award for Financial Inclusion at the Singapore Fintech Festival, endorsed by the Monetary Authority of Singapore (MAS). The company was also ranked as the second-highest Malaysian company in the "High-Growth Companies in Asia Pacific 2024" list by Statista and The Financial Times.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

PolicyStreet Offers Uncapped 10% Car Insurance Savings with '10+10' Promo

SHENZHEN, China, Dec. 30, 2025 /PRNewswire/ -- On December 5, 2025, Dr. Lu Xianping, Founder, Chairman of Shenzhen Chipscreen Biosciences Co., Ltd, has been named the Chinese mainland winner of the EY Entrepreneur Of The Year™ 2025 awards.

This recognition honors his outstanding contributions to advancing new-quality productive forces and driving innovation within the pharmaceutical industry.

The award program, themed "Two Decades of Unwavering Strength, Forging Ahead in the New Era," celebrates entrepreneurs who shoulder new-era responsibilities and contribute significantly to national prosperity and social progress.

Dr. Lu Xianping stands as a distinguished scientist and entrepreneur in China's innovative pharmaceutical sector. He earned a Ph.D. in Molecular Biology from Peking Union Medical College, pursued postdoctoral research in the U.S., and successfully founded two biopharmaceutical companies. Driven by the mission to "develop affordable innovative drugs for ordinary people," he chose to return to China and established Chipscreen Biosciences in 2001.

Against the backdrop of China's historical focus on generic drugs, Dr. Lu dedicated himself to researching first-in-class drugs with entirely novel mechanisms of action. By building a new drug discovery and evaluation platform based on chemical genomics and AI-assisted design, he significantly improved R&D success rates and shortened development cycles. Under his leadership, Chidamide became China's first original small-molecule anti-tumor innovative drug and the country's first pharmaceutical product to be globally licensed out. It filled a critical gap in treating peripheral T-cell lymphoma in China and has extended new hope to patients with breast cancer, adult T-cell leukemia, diffuse large B-cell lymphoma and other malignancies. Chiglitazar Sodium, developed over 19 years for Type 2 diabetes, marked a historic breakthrough as the world's first PPAR pan-agonist. Both drugs have been included in China's National Reimbursement Drug List (NRDL), substantially reducing patients' financial burdens. In the current pipeline, multiple drug candidates with significant first-in-class potential are expected to deliver novel therapeutic options for chronic diseases such as Alzheimer's disease.

Dr. Lu has actively promoted improvements in China's pharmaceutical ecosystem, including the evolution of innovative drug review pathways, NRDL inclusion mechanisms and capital market reforms. Under his guidance, Chipscreen has donated over RMB 700 million worth of medicines, helping more than 10,000 patients alleviate treatment costs. Dedicated to developing first-in-class therapies with novel targets, structures and mechanisms, he has been hailed by international media as "China's pioneer of original innovative drugs."

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Dr. Lu Xianping, Founder, Chairman of Chipscreen Biosciences named the Chinese mainland winner of the EY Entrepreneur Of The Year™ 2025 awards